We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Tomatoes in Diet Protect Mice from Skin Cancer

By LabMedica International staff writers
Posted on 31 Jul 2017
Cancer researchers working with a mouse model showed that a diet supplemented with tomatoes could protect against skin cancer.

Based on previous studies that had found that prolonged tomato consumption could mitigate ultraviolet (UV) light induced sunburn via unknown mechanisms, investigators at Ohio State University (Columbus, USA) hypothesized that tomato consumption would protect against skin cancer.

To test this theory, the investigators fed diets supplemented with 10% tangerine or red tomato powder to a population of SKH-1 hairless and immunocompetent mice for 35 weeks. More...
From weeks 11 to 20, the mice were exposed to UV light, three times per week, and tumors were tracked weekly. Control mice were fed the same diets but not exposed to UV light.

Results published in the July 11, 2017, online edition of the journal Scientific Reports revealed that significantly fewer tumors developed in male mice consuming red tomato diets or pooled tomato diets compared to controls. Carotenoid levels in plasma and skin were quantitated, with total lycopene higher in skin of tangerine fed animals despite a lower dose. Lycopene, the primary carotenoid in tomatoes, has been shown to be the most effective antioxidant of these pigments.

Metabolomic analyses elucidated compounds derived from tomato glycoalkaloids (including tomatidine and hydroxylated-tomatidine) as significantly different metabolites in skin after tomato supplementation.

Results showing that there were no significant differences in tumor number for female mice in the study confirmed previous findings that male mice developed tumors earlier after UV exposure and that their tumors are more numerous, larger, and more aggressive.

"This study showed us that we do need to consider sex when exploring different preventive strategies," said senior author Dr. Tatiana Oberyszyn, professor of pathology at Ohio State University. "What works in men may not always work equally well in women and vice versa."

Related Links:
Ohio State University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.